Published in J Clin Endocrinol Metab on June 01, 1999
Polymorphisms in the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with variation in vertebral bone mass, vertebral bone size, and stature in whites. Am J Hum Genet (2004) 1.97
The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart (2001) 1.86
Genetic susceptibility to lead poisoning. Environ Health Perspect (2000) 1.70
Associations of blood pressure and hypertension with lead dose measures and polymorphisms in the vitamin D receptor and delta-aminolevulinic acid dehydratase genes. Environ Health Perspect (2001) 1.33
Polymorphism in the vitamin D receptor gene and bone mass in African-American and white mothers and children: a preliminary report. Ann Rheum Dis (2000) 0.94
Vitamin D receptor gene polymorphisms are linked to and associated with adult height. J Med Genet (2005) 0.86
Bone mass pharmacogenetics and ethnic health implications. Clin Cases Miner Bone Metab (2007) 0.76
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2008) 5.27
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2012) 4.88
Dietary supplementation in elderly patients with fractured neck of the femur. Lancet (1990) 4.47
Vitamin-D-receptor-gene polymorphisms and change in lumbar-spine bone mineral density. Lancet (1995) 3.82
Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1998) 2.81
Functional neuroanatomical correlates of hysterical sensorimotor loss. Brain (2001) 2.75
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
Impact of nutrition on muscle mass, strength, and performance in older adults. Osteoporos Int (2012) 2.48
Non-invasive diagnosis of venous thromboembolism in outpatients. Lancet (1999) 2.46
Interpretation and use of FRAX in clinical practice. Osteoporos Int (2011) 2.43
Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab (1992) 2.42
Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab (1991) 2.27
Bone strength and its determinants. Osteoporos Int (2003) 2.25
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel. Ann Oncol (2007) 2.24
Performance of helical computed tomography in unselected outpatients with suspected pulmonary embolism. Ann Intern Med (2001) 2.11
Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism. Lancet (1991) 1.99
Incidence of hip fracture over a 10-year period (1991-2000): reversal of a secular trend. Bone (2007) 1.88
Are younger children at highest risk of renal sequelae after pyelonephritis? Lancet (1997) 1.84
Gain in bone mineral mass in prepubertal girls 3.5 years after discontinuation of calcium supplementation: a follow-up study. Lancet (2001) 1.82
Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency. J Clin Invest (1997) 1.81
A new approach to the development of assessment guidelines for osteoporosis. Osteoporos Int (2002) 1.70
Calcium-enriched foods and bone mass growth in prepubertal girls: a randomized, double-blind, placebo-controlled trial. J Clin Invest (1997) 1.70
Frailty and sarcopenia: definitions and outcome parameters. Osteoporos Int (2012) 1.58
Markers of bone turnover for the management of patients with bone metastases from prostate cancer. Br J Cancer (2000) 1.56
Peak bone mass. Osteoporos Int (1994) 1.52
Pregnancy-associated osteoporosis. Lancet (1996) 1.51
Osteoporosis, genetics and hormones. J Mol Endocrinol (2001) 1.49
Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2. Endocrinology (2005) 1.49
Survival and potential years of life lost after hip fracture in men and age-matched women. Osteoporos Int (2002) 1.47
Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women. Osteoporos Int (2008) 1.45
Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years. Osteoporos Int (2009) 1.44
Value of biomarkers in osteoarthritis: current status and perspectives. Ann Rheum Dis (2013) 1.40
Familial resemblance for bone mineral mass is expressed before puberty. J Clin Endocrinol Metab (1998) 1.39
Stimulation of ADH release by the renin-angiotensin system. Am J Physiol (1970) 1.39
Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines. Clin Ther (1999) 1.35
Inorganic phosphate homeostasis. Renal adaptation to the dietary intake in intact and thyroparathyroidectomized rats. J Clin Invest (1976) 1.29
A prospective study on socioeconomic aspects of fracture of the proximal femur. J Bone Miner Res (1996) 1.27
What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis? Ann Rheum Dis (2013) 1.25
FRAX assessment of osteoporotic fracture probability in Switzerland. Osteoporos Int (2009) 1.19
Evidence for a role of p38 MAP kinase in expression of alkaline phosphatase during osteoblastic cell differentiation. Bone (2002) 1.18
Randomised controlled trial of three day versus 10 day intravenous antibiotics in acute pyelonephritis: effect on renal scarring. Arch Dis Child (2001) 1.17
Impaired biotin status in anticonvulsant therapy. Ann Neurol (1982) 1.17
An osteoporosis clinical pathway for the medical management of patients with low-trauma fracture. Osteoporos Int (2002) 1.15
Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients. Osteoporos Int (1994) 1.15
D-dimer testing for suspected pulmonary embolism in outpatients. Am J Respir Crit Care Med (1997) 1.14
Preferential low bone mineral density of the femoral neck in patients with a recent fracture of the proximal femur. Osteoporos Int (1991) 1.14
Adherence to treatment of osteoporosis: a need for study. Osteoporos Int (2007) 1.13
Sodium-dependent phosphate transport inhibited by parathyroid hormone and cyclic AMP stimulation in an opossum kidney cell line. J Biol Chem (1986) 1.10
Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur. J Am Coll Nutr (1992) 1.09
Tools in the assessment of sarcopenia. Calcif Tissue Int (2013) 1.09
Renal extraction of PAH, GFR, and UNaV in the rat during infusion of angiotensin. Am J Physiol (1969) 1.08
Vitamins and alcoholism. V. Riboflavin, VI. Niacin, VII. Pantothenic acid, and VIII. Biotin. Int J Vitam Nutr Res (1980) 1.08
Influence of strontium on bone mineral density and bone mineral content measurements by dual X-ray absorptiometry. J Clin Densitom (1999) 1.07
Change of tubular reabsorption of sodium and water after renal denervation in the dog. J Physiol (1969) 1.07
Asynchrony between the rates of standing height gain and bone mass accumulation during puberty. Osteoporos Int (1997) 1.06
Plasma concentrations of ADH in conscious and anesthetized dogs. Am J Physiol (1970) 1.06
Treatment of osteoporosis in men. Bone (2012) 1.06
Evaluation of the age-adjusted incidence of hip fractures between urban and rural areas: the difference is not related to the prevalence of institutions for the elderly. Osteoporos Int (2002) 1.06
The influence of pubertal timing on bone mass acquisition: a predetermined trajectory detectable five years before menarche. J Clin Endocrinol Metab (2009) 1.06
Diagnosis of pulmonary embolism by a decision analysis-based strategy including clinical probability, D-dimer levels, and ultrasonography: a management study. Arch Intern Med (1996) 1.05
Weight-bearing bones are more sensitive to physical exercise in boys than in girls during pre- and early puberty: a cross-sectional study. Osteoporos Int (2008) 1.05
Regulation of the metabolism of 25-hydroxyvitamin D3 in primary cultures of chick kidney cells. J Clin Invest (1979) 1.04
Vitamin D supplementation during infancy is associated with higher bone mineral mass in prepubertal girls. J Clin Endocrinol Metab (1999) 1.04
Immunocytochemical detection of phosphatidylinositol 4,5-bisphosphate localization sites within the nucleus. J Histochem Cytochem (1995) 1.04
Genetic aspects of osteoporosis. Curr Opin Rheumatol (1999) 1.04
Primary hyperparathyroidism in familial multiple endocrine neoplasia type I. Long-term follow-up of serum calcium levels after parathyroidectomy. Am J Med (1985) 1.03
Using clinical evaluation and lung scan to rule out suspected pulmonary embolism: Is it a valid option in patients with normal results of lower-limb venous compression ultrasonography? Arch Intern Med (2000) 1.03
Central action of angiotensin in stimulating ADH release. Am J Physiol (1971) 1.03
Do dietary calcium and age explain the controversy surrounding the relationship between bone mineral density and vitamin D receptor gene polymorphisms? J Bone Miner Res (1998) 1.03
Vitamin status in patients on chronic anticonvulsant therapy. Int J Vitam Nutr Res (1982) 1.03
Relation between alkaline phosphatase and Ca 2+ -ATPase in calcium transport. Nat New Biol (1972) 1.02